Page last updated: 2024-08-23

1-deoxynojirimycin and phenylalanine

1-deoxynojirimycin has been researched along with phenylalanine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haslbeck, M; Jakob, S; Kellerer, M; Linn, T1
Faridmoayer, A; Scaman, CH1
Kim, SS; Koide, M; Nagasawa, Y; Sawada, T; Shiotani, H; Terashita, D; Yokoyama, M1
Fukase, H; Harigai, M; Iida, S; Ikeda, S; Kasahara, N; Miyata, K; Ohba, Y; Saito, T; Takano, Y; Terao, K1

Reviews

1 review(s) available for 1-deoxynojirimycin and phenylalanine

ArticleYear
[Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
    MMW Fortschritte der Medizin, 2003, Dec-18, Volume: 145, Issue:51-52

    Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Carbamates; Contraindications; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Fasting; Follow-Up Studies; Germany; Glucosamine; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Imino Pyranoses; Insulin; Metformin; Middle Aged; Nateglinide; Obesity; Patient Compliance; Phenylalanine; Pioglitazone; Piperidines; Practice Guidelines as Topic; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Time Factors

2003

Trials

2 trial(s) available for 1-deoxynojirimycin and phenylalanine

ArticleYear
Comparison of effects of α-Glucosidase inhibitors and glinide drugs on endothelial dysfunction in diabetic patients with coronary artery disease.
    Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:1

    Topics: 1-Deoxynojirimycin; Aged; Aged, 80 and over; Coronary Artery Disease; Cyclohexanes; Diabetic Angiopathies; Dyslipidemias; Endothelium, Vascular; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Nateglinide; Phenylalanine

2014
A Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction Study of Tofogliflozin (a New SGLT2 Inhibitor) and Selected Anti-Type 2 Diabetes Mellitus Drugs.
    Drug research, 2016, Volume: 66, Issue:2

    Topics: 1-Deoxynojirimycin; Adult; Benzhydryl Compounds; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Interactions; Glucose; Glucosides; Healthy Volunteers; Humans; Hypoglycemic Agents; Inositol; Male; Metformin; Middle Aged; Nateglinide; Phenylalanine; Pioglitazone; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; Urine; Young Adult

2016

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and phenylalanine

ArticleYear
Binding residues and catalytic domain of soluble Saccharomyces cerevisiae processing alpha-glucosidase I.
    Glycobiology, 2005, Volume: 15, Issue:12

    Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Amino Acid Sequence; Binding Sites; Bromosuccinimide; Catalysis; Catalytic Domain; Diethyl Pyrocarbonate; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Enzyme Inhibitors; Gene Expression Regulation, Fungal; Glycoside Hydrolases; Glycosylation; Glyoxal; Histidine; Hydrolysis; Lysine; Molecular Sequence Data; Peptides; Phenylalanine; Protein Binding; Protein Structure, Tertiary; Saccharomyces cerevisiae; Temperature; Tetranitromethane; Time Factors; Trisaccharides; Trypsin; Tryptophan; Tyrosine

2005